Kenvue Inc. (KVUE) NYSE

16.88

+0.42(+2.55%)

Updated at November 07 04:00PM

Currency In USD

Kenvue Inc.

Address

199 Grandview Road

Skillman, NJ 08558

United States of America

Phone

(732) 524-0400

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

22000

First IPO Date

May 04, 2023

Key Executives

NameTitlePayYear Born
Mr. Thibaut MongonChief Executive Officer & Director4.2M1971
Ms. Meredith StevensChief Operations Officer1.83M1963
Mr. Carlton LawsonGroup President of EMEA & Latin America2.3M1969
Ms. Ellie Bing XieGroup President of Asia Pacific2.63M1970
Mr. Amit BanatiChief Financial Officer01969
Ms. Sofya TsinisHead of Investor Relations0N/A
Ms. Heather R. HowlettChief Accounting Officer01978
Dr. Caroline Tillett Ph.D.Chief Scientific Officer01972
Mr. Matthew OrlandoGeneral Counsel01977
Mr. Bernardo TavaresChief Data & Technology Officer01968

Description

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.